Poseida Therapeutics, Inc (PSTX) PT Lowered to $17 at Piper Sandler
Tweet
Share
E-mailGet Alerts PSTX Hot Sheet
Price: $9.50 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff lowered the price target on Poseida Therapeutics, Inc (NASDAQ: PSTX) to $17.00 (from $30.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Citi raises EquipmentShare price target to $22, keeps Neutral
- Vincorion SE (V1NC:GR) PT Raised to EUR27 at JPMorgan
- Leonardo Spa (LDO:IM) (FINMY) PT Raised to EUR72 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
